Results 31 to 40 of about 6,827 (229)

New possibilities in the treatment of Meniere's disease [PDF]

open access: yesVojnosanitetski Pregled, 2002
The results of the treatment of Meniere's disease by intratympanic instillation of gentamicin in 32 patients over a 24-months period were analyzed. The receded vestibular function was found in 96,8% patients whereas in the remaining 3,2% pronounced ...
Milanović Nada   +3 more
doaj   +1 more source

Emerging pharmacotherapy of tinnitus [PDF]

open access: yes, 2009
Tinnitus, the perception of sound in the absence of an auditory stimulus, is perceived by about 1 in 10 adults, and for at least 1 in 100, tinnitus severely affects their quality of life.
Ana Belén Elgoyhen   +43 more
core   +1 more source

Assessment of complications due to intratympanic injections

open access: yesWorld Journal of Otorhinolaryngology - Head and Neck Surgery, 2016
AbstractObjectiveThe purpose of the study is to report and to analyze the complications following intratympanic injections (ITI) of steroids. The occurrence rate of complications at different ITI sites, four quadrants of eardrum, was also compared.MethodsA retrospective clinical review in a medical center.
Yu-Chuan Liu   +3 more
openaire   +3 more sources

Longitudinal Results With Intratympanic Dexamethasone in the Treatment of Ménière’s Disease [PDF]

open access: yes, 2008
To assess patient satisfaction with vertigo control using intratympanic (IT) dexamethasone (12 mg/mL) for medically refractory unilateral Meniere's disease. STUDY DESIGN: Retrospective study.
Boleas-Aguirre, M.S. (María Soledad)   +4 more
core   +1 more source

The Effects of Experimental Intratympanic Steroid Administration on Organ of Corti Type 1 Spiral Ganglion

open access: yesInternational Archives of Otorhinolaryngology, 2018
Introduction It is unclear how effective is the intratympanic (IT) steroid treatment on organ of Corti type 1 spiral ganglion, its optimal dosage and frequency of administration.
Turgay Topcuoglu   +5 more
doaj   +1 more source

Intratympanic gentamicin treatment for Ménière's disease: A randomized, double-blind, placebo-controlled trial on dose efficacy - results of a prematurely ended study [PDF]

open access: yes, 2014
Background: Gentamicin is used as a therapeutic agent for Ménière's disease because of its vestibulotoxicity causing chemo-ablation of the vestibular sensory epithelia. Its use has increased in recent years. However, there is still no consensus about the
Bremer, H.G. (Hendrik G.)   +9 more
core   +4 more sources

Dexamethasone does not affect endolymphatic hydrops (EH) in patients with Meniere's disease within 24 h, and intratympanic administration of gadolinium plus dexamethasone simplifies high-quality imaging of EH using a novel protocol of 7 min

open access: yesJournal of Otology, 2022
Background: Intratympanic administration of gadolinium chelate allows for a better visualization of endolymphatic hydrops (EH) using MRI than intravenous injection and was recently further improved to facilitate high-quality imaging of EH in 7 min.
Jing Zou   +6 more
doaj   +1 more source

Round window membrane and delivery of biologically active agents into the cochlea [PDF]

open access: yes, 2010
Establishing efficient methods for local administration of drugs to the inner ear has great clinical relevance for the management of inner ear disorders. However, the administration route remains a critical issue.
Saber, Amanj K.
core   +1 more source

Intratympanic membrane cholesteatoma after traumatic tympanic membrane perforation: a case report

open access: yesJournal of Medical Case Reports, 2023
Background Intratympanic membrane cholesteatoma presents as an asymptomatic, white, round mass on the tympanic membrane, and is usually detected incidentally in children.
Junhui Jeong, Hyun Seung Choi
doaj   +1 more source

Prevention of cisplatin-induced hearing loss in children: Informing the design of future clinical trials. [PDF]

open access: yes, 2018
Cisplatin is an essential chemotherapeutic agent in the treatment of many pediatric cancers. Unfortunately, cisplatin-induced hearing loss (CIHL) is a common, clinically significant side effect with life-long ramifications, particularly for young ...
Chang, Kay   +9 more
core   +1 more source

Home - About - Disclaimer - Privacy